General Court held that a selective redrawal of marketing authorizations for a first generation product was an abuse of a … timing and content of marketing efforts by an originator company. Marketing is pro-competitive in almost all cases, but due … to the special regulatory context in the pharmaceutical industry, marketing by an originator company can be used in an …